Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Tirzepatide (Mounjaro) was approved by the FDA in May 2022 for use in combination with diet and exercise to improve blood sugar control in adults with type 2 diabetes
Job loss, unexpected expenses, or changes in financial circumstances may make continued treatment temporarily impossible
This evaluation determines whether GLP-1 therapy is appropriate and which formulationinjection or oralsuits your lifestyle and preferences
After the initial four-week period at 0.25 mg weekly, patients typically advance to 0.5 mg weekly
Biologics are usually stored at 2-8C but should be normalized to room temperature prior to being administered
Adjustments and Treatment Plans: Based on the assessment and diagnostic findings, healthcare providers can recommend appropriate adjustments to your treatment plan
US$ 21.32
US$ 26.96
US$ 23.82
US$ 29.32
